News & Updates
Filter by Specialty:
Polypill strategy triumphs in reducing MACE post-MI
12 Sep 2022
byRoshini Claire Anthony
A polypill comprising aspirin, ramipril, and atorvastatin, significantly reduced the incidence of major adverse cardiovascular (CV) events in patents with a recent myocardial infarction (MI), according to results of a phase III trial presented at ESC 2022.
Polypill strategy triumphs in reducing MACE post-MI
12 Sep 2022Antihypertensive drugs confer durable BP reduction in white-coat hypertension
11 Sep 2022
Antihypertensive medications prove to be effective and lasting in decreasing office blood pressure (BP) among individuals with white-coat hypertension (WCH), suggests a study.